CLINICAL_TRIALS
trial_result
· 2024-03-29
Clinical Trial Update: Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial evaluating the combined effect of oxytocin and naltrexone on stress- and alcohol cue-induced craving in alcohol use disorder has complet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Alcohol Use Disorder, Alcoholism | Phase 2, Phase 3 | Status: COMPLETED